{
    "clinical_study": {
        "@rank": "26566", 
        "arm_group": [
            {
                "arm_group_label": "Yili \"Mei Yi Tian\" lactobacillus drink", 
                "arm_group_type": "Active Comparator", 
                "description": "100ml of Yili \"Mei Yi Tian\" active lactobacillus drink to be taken once per day at 10am daily during the 84-days intervention"
            }, 
            {
                "arm_group_label": "recombined milk drink contains no lactobacillus", 
                "arm_group_type": "Placebo Comparator", 
                "description": "100ml of recombined milk drink contains no lactobacillus to be taken once per day at 10am daily during the 84-days intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Study on Evaluating the Promote Effect of Yili Mei Yi Tian Active Lactobacillus Drink on\n      Immunity and Physical Intestinal Canal"
        }, 
        "brief_title": "Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Immunization", 
            "Human Influenza", 
            "Common Cold", 
            "Constipation", 
            "Dyspepsia", 
            "Flatulence", 
            "Abdominal Pain"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Abdominal Pain", 
                "Common Cold", 
                "Constipation", 
                "Dyspepsia", 
                "Flatulence", 
                "Influenza, Human"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 25 to 45 years sub-health white-collars, catch cold for 4 to 6 times in last\n             year, with low immunity;\n\n          -  Non-specific and/or moderate constipation;\n\n          -  Irregular or occasional gastrointestinal disorders (flatulence, gurgling, feeling\n             heavy after eating, abdominal pain);\n\n          -  Slow transit or irregular bowels movements (abnormal feces solidity, bowel movements\n             decreased, e.g. every 2-3 days or less than 3 times per week);\n\n          -  Able to understand the nature and purpose of the study including potential risks and\n             side effects;\n\n          -  Willing to consent to study participation and to comply with study requirements\n\n        Exclusion Criteria:\n\n          -  Diagnosed as immunity-low associated with chronic disease;\n\n          -  Diagnosed as chronic constipation;\n\n          -  Treated gastrointestinal symptoms;\n\n          -  Currently suffering from diarrhea;\n\n          -  Suffering from rhinitis chronic, laryngitis, labored breathing that similar to flu\n             symptoms. Such as chronic allergic rhinitis, asthma, COPD;\n\n          -  Treatment by analgesic such as aspirin and paracetamol;\n\n          -  Had laxatives or other remedies to promote digestion 2 weeks prior to the study\n             start;\n\n          -  Consuming dairy products or supplements containing pro/pre-biotic 10 days prior to\n             the study start;\n\n          -  Long-term use of any prescription or OTC medication that inhibit or prevent flu\n             symptoms, including but not limited to, antihistamine,  pectoral, high doses of\n             vitamin C;\n\n          -  Recent use (within 3 months of screening) of any prescription or OTC medication that\n             significantly affects immune response, such as antibiotic;\n\n          -  Recent inoculation (within 6 months of screening) of influenza vaccine, or other\n             vaccine in 15 days;\n\n          -  History of alcohol, drug, or medication abuse;\n\n          -  Pregnant or breastfeeding women;\n\n          -  Participation in another study with any investigational product within 3 months of\n             screening\n\n          -  Any comorbidity that could, in the opinion of the investigator, preclude the\n             subject's ability to successfully and safely complete the study or that may confound\n             study outcomes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01677715", 
            "org_study_id": "YL/CL-003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Yili \"Mei Yi Tian\" lactobacillus drink", 
                "description": "100ml of Yili \"Mei Yi Tian\" active lactobacillus drink to be taken once per day at 10am daily during the 84-days intervention", 
                "intervention_name": "Yili \"Mei Yi Tian\" active lactobacillus drink", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "recombined milk drink contains no lactobacillus", 
                "description": "100ml of recombined milk drink contains no lactobacillus to be taken once per day at 10am daily during the 84-days intervention", 
                "intervention_name": "recombined milk drink contains no lactobacillus", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 12, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "ChaoYang District", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "NanMoFang Community Health Service Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baoshan District", 
                        "country": "China", 
                        "state": "Shanghai"
                    }, 
                    "name": "Shanghai Municipal Food and Drug Administration Baoshan Office"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study on Evaluating the Promote Effect of Yili Mei Yi Tian Active Lactobacillus Drink on Immunity and Physical Intestinal Canal", 
        "overall_official": [
            {
                "affiliation": "Inner Mongolia Hilo Industrial Group Co., Ltd", 
                "last_name": "Ying An, Ph.D", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Digestive system Dept.", 
                "last_name": "Leiming Xu", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Kidney Dept.", 
                "last_name": "Gengru Jiang", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in constipation condition", 
                "safety_issue": "No", 
                "time_frame": "Baseline & 3 months"
            }, 
            {
                "measure": "Assess severity of flu symptoms", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01677715"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in immune markers such as antibodies and interleukins", 
                "safety_issue": "No", 
                "time_frame": "Baseline & 3 months"
            }, 
            {
                "measure": "Change in gut resident flora", 
                "safety_issue": "No", 
                "time_frame": "Baseline & 3 months"
            }
        ], 
        "source": "Inner Mongolia Yili Industrial Group Co., Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inner Mongolia Yili Industrial Group Co., Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}